rhodioloside has been researched along with epirubicin in 1 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 5,453 | 1,838 | 1,570 |
| Protein | Taxonomy | rhodioloside (IC50) | epirubicin (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.75 | ||
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, LC; Gao, CH; Shen, D; Shen, WS; Zhang, H | 1 |
1 trial(s) available for rhodioloside and epirubicin
| Article | Year |
|---|---|
Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Epirubicin; Female; Glucosides; Humans; Middle Aged; Phenols; Reactive Oxygen Species; Rhodiola; Ventricular Dysfunction, Left | 2012 |